|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
J Thorac Cardiovasc Surg 2009;138:316-323
© 2009 The American Association for Thoracic Surgery
Acquired Cardiovascular Disease |
Inova Heart and Vascular Institute, Falls Church, Va
Received for publication January 5, 2009; revisions received February 20, 2009; accepted for publication March 8, 2009. * Address for reprints: Niv Ad, MD, Cheif, Cardiac Surgery, Inova Heart and Vascular Institute, 3300 Gallows Rd, Falls Church, VA 22042. (Email: niv.ad{at}inova.org).
Objectives: Percutaneous intervention for coronary revascularization is associated with an increased risk of repeat revascularization, especially in patients with diabetes mellitus. In this study we sought to examine the effect of previous percutaneous intervention on the rate of adverse perioperative outcome and intermediate-term survival in patients undergoing coronary artery bypass surgery.
Methods: Between January 1, 2001, and December 31, 2006, 1758 consecutive patients with diabetes mellitus who underwent first-time isolated coronary artery bypass surgery were identified. Survival and major perioperative complications for 1537 patients who did not have prior percutaneous intervention (group 1) were compared with those in 221 patients with prior percutaneous intervention (group 2) after adjusting for baseline risk factors. Vital status was determined by using the National Death Index and Social Security Death Index. Age-adjusted survival at 2 years' follow-up was calculated with the Cox singular proportional hazards model.
Results: At baseline, group 2 patients had higher incidences of hypercholesterolemia and myocardial infarction. Compared with group 1 patient, group 2 patients had significantly higher operative mortality (adjusted odds ratio, 4.05; 95% confidence interval, 1.41–11.63), perioperative major adverse cardiac events (adjusted odds ratio, 2.72; 95% confidence interval, 1.08–6.85), and atrial fibrillation (adjusted odds ratio, 1.97; 95% confidence interval, 1.29–3.01). Group 2 patients had worse age-adjusted survival at 2 years' follow-up (93.4% vs 87.4%, P < .017).
Conclusions: Patients with diabetes mellitus and a history of percutaneous coronary stenting before coronary artery bypass surgery were found to have an increased risk of operative death, increased perioperative complications, and decreased age-adjusted survival at 2 years' follow-up.
Related Article
J. Thorac. Cardiovasc. Surg. 2009 138: 276-277.
This article has been cited by other articles:
![]() |
N. Bonaros, D. Vill, D. Wiedemann, K. Fischler, G. Friedrich, O. Pachinger, M. Grimm, and T. Schachner Major risk stratification models do not predict perioperative outcome after coronary artery bypass grafting in patients with previous percutaneous intervention Eur J Cardiothorac Surg, June 1, 2011; 39(6): e164 - e169. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Adams, J. Chikwe, F. Filsoufi, and A. C. Anyanwu The Year in Cardiovascular Surgery J. Am. Coll. Cardiol., March 29, 2011; 57(13): 1425 - 1444. [Full Text] [PDF] |
||||
![]() |
H. L. Lazar Detrimental effects of coronary stenting on subsequent coronary artery bypass surgery: is there another flag on the field? J. Thorac. Cardiovasc. Surg., August 1, 2009; 138(2): 276 - 277. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |